1. Background {#sec1}
=============

Type 2 diabetes mellitus (T2DM) in itself is associated with poorer health-related quality of life (HRQoL) \[[@B1]\]. People with T2DM are susceptible to develop long term complications, such as retinopathy, neuropathy, nephropathy, and chronic heart disease, which negatively influence HRQoL \[[@B2]\]. To prevent or delay development of these long term complications, adequate treatment modalities are necessary which mainly involve lifestyle changes and pharmacological treatment. Adherence to medication prescription and implementing life style changes are often better maintained and facilitated, when patients consider themselves more responsible for their treatment and have more knowledge regarding the causes and consequences of their disease. Improvements in knowledge about their disease can be described as promotion of health literacy. e-Health applications, such as web-portals, teleconsultation, and online care platforms, have the potential to support patients in changing lifestyle and taking more responsibility for their own health \[[@B3]\]. However, varying effects on clinical outcomes, quality of life, degree of self-care, perceived stress levels, patient satisfaction, and costs have been reported \[[@B4]--[@B10]\].

Previous studies showed that patients who were interested in using an online care platform were more often male, younger, and higher educated \[[@B11], [@B12]\]. However, within the subgroup of interested patients these differences were not found between actual users and nonusers \[[@B11]\]. In addition, other factors associated with higher portal enrollment and utilization are higher income, nonblack race, higher self-efficacy, and having better regulated diabetes \[[@B13]\]. Identifying the differences between platform users and nonusers could provide information to help target and support nonusers in becoming more active in their diabetes self-management.

The aim of the present, explorative study was to investigate possible differences in demographic, clinical, and psychological characteristics between users and nonusers of the platform e-Vita.

2. Methods {#sec2}
==========

2.1. Study Design {#sec2.1}
-----------------

We performed a cross-sectional analysis of baseline data of users and nonusers of the online patient platform e-Vita. Data was obtained from a prospective observational cohort study. Detailed information about the methods and design of the study as a whole can be found elsewhere \[[@B14]\].

2.2. Study Population and Setting {#sec2.2}
---------------------------------

Forty-three out of 110 general practices in the Drenthe region of the Netherlands invited their T2DM patients for participation in a prospective observational cohort study concerning quality of care and HRQoL. Patients were also invited to use the online care platform e-Vita, in addition to their usual treatment. Patients interested in using the platform were registered by their practice nurse (PN) and received a user ID. In this ongoing study, participants were recruited from May 2012 onward. The current analysis includes patients recruited from May 2012 till March 2014.

2.3. Measurements {#sec2.3}
-----------------

Demographic and clinical data were obtained from the personal health record systems of the general practitioners (GP), based on a core dataset of T2DM related information as advised by the Dutch Diabetes Federation and the Dutch College of General Practitioners \[[@B14]\]. All T2DM patients participating in the study filled in a range of validated questionnaires concerning perceived quality of life measured by the EuroQol Five Dimension (EQ-5D) Scale \[[@B15]--[@B17]\], emotional well-being measured by the World Health Organization Wellbeing Index 5-Item (WHO-5) questionnaire \[[@B18], [@B19]\], diabetes-related distress measured by the Problem Areas in Diabetes 5-Item (PAID-5) questionnaire \[[@B20]\], diabetes self-care behavior measured by 7 Dimensions of the Summary of Diabetes Self-Care Activities (SDSCA) questionnaire \[[@B21]\], and quality of received care measured by the Europep \[[@B22]\]. Suboptimal emotional well-being was defined by a raw score lower than 13 on the WHO-5 \[[@B23]\]. Additional questions about smoking habits, employment, and educational background were also included. To identify users and nonusers, registration data from the application software and log-files were used.

2.4. Description of e-Vita Platform {#sec2.4}
-----------------------------------

The e-Vita platform for T2DM patients (accessible through the login button on <https://www.e-vita.nl/>) \[[@B11], [@B14], [@B24]\] contains the following components: (1) an overview of health data concerning annual check-ups from 2009 onward, (2) educational modules meant to support care through self-management by setting person-specific goals and actions \[[@B25]\], (3) prompting patient self-monitoring of clinical values, (4) educational modules aimed at increasing diabetes knowledge, and (5) providing reliable information on T2DM in general.

2.5. Users and Nonusers {#sec2.5}
-----------------------

Information about login status and log-data were used to group patients into nonusers and users. All patients who logged in at least once were considered as users. Patients who had been online for at least two sessions with a minimum of five minutes per session were defined as "active" users; other patients were defined as "curious" users. A session included all logins to the platform within thirty minutes \[[@B24]\].

2.6. Statistical Analyses {#sec2.6}
-------------------------

Statistical analyses were performed using SPSS version 20 (IBM Corporation, Somers, NY, USA). Quantitative variables are described in means and standard deviations when normally distributed; otherwise medians and interquartile ranges are also described. Categorical variables are described in numbers and percentages. To identify differences in the domains of interest between the different groups of users, the Linear Mixed Models procedure was used, with groups of users being fixed factors (nonusers being the reference group), while adjusting for age and sex. Fisher\'s exact test was used for categorical data. Differences were considered to be significant at a *p* value of \<0.05. In addition, results are adjusted for age and gender. Because of the explorative design of this study, no corrections for multiple testing were made \[[@B26]\]. Instead, the calculated *p* values are only used as an indication of to what extent a difference could be interesting for further research.

2.7. Ethics {#sec2.7}
-----------

This study was approved by the Medical Ethical Review Committee of Isala, Zwolle, the Netherlands, and registered in Clinicaltrials.gov under number [NCT01570140](https://clinicaltrials.gov/ct2/show/NCT01570140?term=NCT01570140&rank=1).

3. Results {#sec3}
==========

In the period from May 2012 to March 2014, 3191 patients were invited to participate in the cohort study and to use the e-Vita platform. 633 patients were registered for care platform use. See [Figure 1](#fig1){ref-type="fig"} for the patient flow.

[Table 1](#tab1){ref-type="table"} shows all differences and other notable characteristics for the comparison between nonusers, curious users, and active users of the platform. No differences were found in demographical characteristics between nonusers, curious users, and active users. HbA1c level of nonusers was higher compared to curious users (*p* = 0.038) and to active users (*p* = 0.001). Curious and active users were more often known with hypertension compared to nonusers (*p* = 0.025). Curious users assessed the GP better on one question of the Europep compared to nonusers and active users (*p* = 0.047). Curious users scored higher on EQ-5D (*p* = 0.030) and EQ-VAS (0.032) compared to nonusers, with no significant differences between curious users and active users or nonusers and active users. In addition, curious users\' WHO-5 score as well as their answers to the individual WHO-5 questions reported less depressive symptoms compared to nonusers and active users. Curious users scored lower on PAID-5 compared to nonusers (*p* = 0.016), with no significant differences between curious users versus active users and nonusers versus active users. Curious users performed better on one dimension of self-reported self-management activities (medication intake) compared to nonusers (*p* = 0.020), with no significant difference between curious users versus active users and nonusers versus active users. [Table 2](#tab2){ref-type="table"} shows the Cronbach\'s alpha for all the multi-item scales.

See [Appendix A](#secA){ref-type="sec"} for tables with all characteristics as mentioned in the methods section for the comparison between nonusers and users. See [Appendix B](#secB){ref-type="sec"} for tables with all characteristics for the comparison between nonusers, curious users, and active users.

The differences in characteristics between nonusers, curious users, and active users have also been adjusted for age and gender in a multivariate analysis. The results are shown in [Table 3](#tab3){ref-type="table"}. *p* values below 0.05 were found for differences regarding HbA1c between active users and nonusers (−3.624 mmol/mol) as well as between curious users and nonusers (−1.989 mmol/mol) and for differences between curious users and nonusers regarding EQ-5D (0.044), EQ-VAS (4.611), WHO-5 (3.609), PAID-5 (−0.929), and medication intake (0.236).

4. Discussion {#sec4}
=============

In this exploratory study we found that only a small amount of clinical and psychological characteristics were associated with platform use. Curious users as well as active users had lower HbA1c compared to nonusers, which is in agreement with other studies \[[@B27], [@B28]\]. The more frequent presence of hypertension in curious and active users, however, contradicts with these studies. Curious users scored higher on EQ-5D and EQ-VAS and lower on PAID-5. Curious users scored also better on medication intake, which may reflect higher self-efficacy, in agreement with the study by Sarkar et al. \[[@B29]\]. After adjustment for age and gender, the difference in WHO-5 score between curious users and nonusers was also significant.

We observed that most of the patients, who were registered for platform use, never logged on. This could be influenced by (an insufficient) intrinsic motivation and (no) intention to change behaviours. Another explanation could be that patients do not see the platform as useful or as an added value to regular treatment. As an alternative explanation, login procedures might be too difficult and after trying for some time they might give up.

Previous research showed that web-portals and online care platforms are susceptible to implementation problems, low participation rates, and nonadherence, which, amongst others, can be caused by a mismatch in expectations between software developers, health care providers, and users \[[@B30]--[@B37]\]. Other reasons for limited use of care platforms or nonadherence rates are as follows: abundance of functionalities on a platform, no connection with the needs of patients, implementation by management only without active involvement of care providers, no embedding in the regular care process, no space for habituation, underestimation of the complexity of lifestyle changes in general \[[@B38]\], and barriers to easy access to a portal (e.g., complicated login procedures). Despite the use of focus groups for designing and testing, these reasons might also be applicable to the e-Vita platform and improvements could be made.

The current study has some limitations. A preselection of participants could in part have influenced results. Only patients who expressed their interest received a user-ID \[[@B14]\]; see also [Figure 1](#fig1){ref-type="fig"}. Relevant and significant differences might be more difficult to find.

Data were not complete for all patients, especially with regard to complications and risk factors (complete for 50--60%; see Tables [6](#tab6){ref-type="table"} and [11](#tab11){ref-type="table"}). This may have led to an underestimation of presence of complications and risk factors. In addition, not all patients were seen by their GP or PN for the regular yearly check-up in the year 2012, which contributed to missing values in clinical parameters. Some questions about the assessment of the general practice and the general practitioner were poorly answered in general. A reason for this could be social desirability; patients may not like to be negative about their GP and prefer not answering these questions.

Although the online care platform e-Vita was designed for being suitable for all T2DM patients, a general assumption is that those with greater severity of disease, lower mood, progression of the disease, and complications would probably benefit most from an online care platform. However, when assessing the presented results, these patients use the platform the least.

Possibly, the current users were already more in control of their life and health and could therefore be more open to other forms of support, including e-Health facilities. Challenges to reach other patients remain manifold. A patients\' passive attitude may not be overcome by only providing e-facilities, since one\'s interest and the sense of disease burden are low or even absent in the majority of the T2DM population. Factors as knowledge, motivation, and intention could be considered in future research.

The authors wish to thank all the participating patients and primary health care workers in the Drenthe region of the Netherlands. Thanks also are due to Jurriaan Kok for his support and for managing the DM part of the e-Vita research program and all coordinators and supporters within the foundation Care Within Reach (in Dutch: stichting Zorg Binnen Bereik). The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this paper: the study has been funded by foundation Care Within Reach (in Dutch: stichting Zorg Binnen Bereik).

A. Results of Users and Nonusers of the Online Care Platform e-Vita {#secA}
===================================================================

See Tables [4](#tab4){ref-type="table"}, [5](#tab5){ref-type="table"}, [6](#tab6){ref-type="table"}, [7](#tab7){ref-type="table"}, and [8](#tab8){ref-type="table"}.

B. Results of Curious Users, Active Users, and Nonusers of the Online Care Platform e-Vita {#secB}
==========================================================================================

See Tables [9](#tab9){ref-type="table"}, [10](#tab10){ref-type="table"}, [11](#tab11){ref-type="table"}, [12](#tab12){ref-type="table"}, and [13](#tab13){ref-type="table"}.

EQ-5D:

:   EuroQol-5 Dimensions

EQ-VAS:

:   EuroQol Visual Analogue Scale

GFR:

:   Glomerular filtration rate

GP:

:   General practitioner

HRQoL:

:   Health-related quality of life

MDRD:

:   Modification of Diet in Renal Disease

PAID-5:

:   Problem Areas in Diabetes-5 questions

PN:

:   Practice nurse

SDSCA:

:   Summary of Diabetes Self-Care Activities

T2DM:

:   Type 2 diabetes mellitus

WHO-5:

:   WHO-Five Item Measure of Well-Being.
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###### 

Differences and notable characteristics of nonusers, curious users, and active users.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *n* (%) or mean (SD) \                                                                                       Nonusers (*n* = 361)   Missing      Curious users (*n* = 184)   Missing     Active users (*n* = 88)   Missing     Univariate \
  Demographic and clinical parameters                                                                                                                                                                                            *p* value
  ------------------------------------------------------------------------------------------------------------ ---------------------- ------------ --------------------------- ----------- ------------------------- ----------- --------------
  Men                                                                                                          214 (59.3)             0 (0)        113 (61.4)                  0 (0)       50 (56.8)                 0 (0)       0.760

  Age in years                                                                                                 62.1 ± 9.5 \           0 (0)        61.8 ± 9.5 \                0 (0)       62.0 ± 9.4 \              0 (0)       0.935
                                                                                                               63.0 (56.5--68.0)                   62.0 (56.3--68.0)                       63.0 (57.0--67.0)                     

  Ethnicity                                                                                                                                                                                                                       

   Caucasian                                                                                                   292 (99.0)             66 (18.3)    143 (100)                   41 (22.3)   65 (100)                  23 (6.1)    0.706

   Other                                                                                                       3 (1.0)                             0 (0)                                   0 (0)                                 0.382

  Employment                                                                                                                                                                                                                      

   Fulltime/part-time working                                                                                  99 (34.3)              72 (19.9)    61 (39.6)                   30 (16.3)   20 (23.8)                 4 (4.5)     0.063

   Retired                                                                                                     134 (46.4)                          70 (45.5)                               46 (54.8)                              

   Unemployed/housekeeper                                                                                      38 (13.1)                           20 (13.0)                               9 (10.7)                               

   Incapacitated                                                                                               18 (6.2)                            3 (1.9)                                 9 (10.7)                               

  Educational level                                                                                                                                                                                                               

   None                                                                                                        0 (0)                  73 (20.2)    1 (0.7)                     31 (16.8)   0 (0)                     4 (4.5)     0.125

   Primary school                                                                                              24 (8.3)                            9 (5.9)                                 4 (4.8)                                

   Low                                                                                                         127 (44.1)                          52 (34.0)                               27 (32.1)                              

   Intermediate                                                                                                86 (29.9)                           51 (33.3)                               30 (35.7)                              

   High                                                                                                        51 (17.7)                           40 (26.1)                               23 (27.4)                              

  T2DM duration in years                                                                                       6.2 ± 4.6 \            9 (2.5)      5.7 ± 4.4  \                1 (0.5)     5.4 ± 4.4 \               0 (0)       0.165
                                                                                                               6.0 (2.0--9.0)                      5.0 (2.0--8.0)                          4.5 (2.0--8.0)                        

  HbA1c in mmol/mol                                                                                            50.6 ± 9.5 \           3 (0.8)      48.7 ± 7.4 \                0 (0)       47.0 ± 7.0 \              0 (0)       **0.001**
                                                                                                               50.0 (45.0--54.0)                   48.0 (43.0--54.0)                       46.0 (43.0--50.8)                     

  BMI                                                                                                          29.8 ± 4.9 \           3 (0.8)      30.0 ± 4.8 \                0 (0)       29.9 ± 8.0 \              2 (2.3)     0.921
                                                                                                               29.0 (26.5--32.5)                   29.3 (26.9--32.3)                       28.0 (26.0--32.6)                     

                                                                                                                                                                                                                                 

  Comorbidities/complications                                                                                                                                                                                                     

   Hypertension                                                                                                191 (84.1)             134 (37.1)   113 (93.4)                  63 (34.2)   51 (92.7)                 33 (37.5)   **0.025**

                                                                                                                                                                                                                                 

  Items of Europep: patients who scored 4 (good) to 5 (excellent) \                                                                                                                                                               
  What is your assessment of the general practitioner over the last 12 months with respect to the following?                                                                                                                     

   Making it easy for you to tell him or her about your problem                                                345 (93.5)             18 (4.7)     187 (97.9)                  17 (8.2)    84 (93.3)                 2 (2.2)     **0.047**

                                                                                                                                                                                                                                 

  *EQ-5D* index-score                                                                                          0.9 ± 0.2              72 (19.9)    0.9 ± 0.1                   32 (17.4)   0.9 ± 0.2                 4 (4.5)     **0.030**

  *EQ-VAS*                                                                                                     74.7 ± 17.4 \          74 (20.5)    79.3 ± 13.8 \               35 (19.0)   76.9 ± 16.5 \             5 (5.7)     **0.032**
                                                                                                               80.0 (60.0--90.0)                   80.0 (73.0--90.0)                       80.0 (0.0--90.0)                      

                                                                                                                                                                                                                                 

  *WHO-5* score indicates suboptimal well-being, screening depression advised                                  36 (12.6)              76 (21.1)    8 (5.3)                     33 (17.9)   9 (10.8)                  1 (1.1)     **0.018**

  *WHO-5* answers advise screening depression                                                                  43 (15.5)              76 (21.1)    6 (4.0)                     33 (17.9)   11 (13.3)                 1 (1.1)     **0.002**

                                                                                                                                                                                                                                 

  *PAID-5* total score                                                                                         2.8 ± 3.1 \            76 (21.1)    1.8 ± 2.4 \                 32 (17.4)   2.2 ± 2.5 \               1 (1.1)     **0.016**
                                                                                                               2.0 (0.0--4.5)                      1.0 (0.0--3.0)                          1.0 (0.0--4.0)                        

                                                                                                                                                                                                                                 

  *SDSCA*                                                                                                                                                                                                                         

   Medication in number of days                                                                                6.7 ± 1.0 \            73 (20.2)    7.0 ± 0.2 \                 30 (16.3)   6.8 ± 0.8 \               4 (4.5)     **0.020**
                                                                                                               7.0 (7.0--7.0)                      7.0 (7.0--7.0)                          7.0 (7.0--7.0)                        
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Cronbach\'s alpha for multi-item scales.

  Multi-item scale                  *α*
  --------------------------------- ----------
  Europep                            
   Total                            0.963
   Subscale general practice        0.966
   Subscale general practitioner    0.840
  EQ-5D                             0.652
  WHO-5                             0.872
  PAID-5                            0.867
  SDSCA                              
   Total                            0.517
   Subscale general diet            0.875
   Subscale specific diet           0^1^
   Subscale total diet              0.446^2^
   Subscale exercise                0.663
   Subscale blood-glucose testing   0.912
   Subscale foot-care               0.593

^1^Because of the negative intercorrelation between the two items Cronbach\'s alpha is reported to be 0.

^2^The alpha for the subscale total diet is lower than that for the subscale general diet due to the low reliability of the subscale specific diet.

###### 

Results of multivariate analysis, adjusted for age and gender.

                           *b*-coefficient   95% CI   *p* value   
  ------------------------ ----------------- -------- ----------- --------------
  T2DM duration in years                                           
   Intercept               0.018             −2.325   2.360       0.988
   Platform use                                                   0.186
   Active users            −0.845            −1.876   0.186       0.108
   Curious users           −0.511            −1.300   0.277       0.203
   Nonusers                Ref. Cat.                               
   Male                    −0.121            −0.832   0.589       0.738
   Female                  Ref. Cat.                               
   Age                     0.101             0.064    0.138       \<0.0005
  HbA1c in mmol/mol                                                
   Intercept               53.431            48.931   57.931      \<0.0005
   Platform use                                                   \<0.0005
   Active users            −3.624            −5.627   −1.621      **\<0.0005**
   Curious users           −1.989            −3.516   −0.462      **0.011**
   Nonusers                Ref. Cat.                               
   Male                    1.103             −0.270   2.477       0.115
   Female                  Ref. Cat.                               
   Age                     −0.055            −0.127   0.016       0.126
  BMI                                                              
   Intercept               37.430            34.658   40.202      \<0.0005
   Platform use                                                   0.924
   Active users            0.079             −1.159   1.317       0.900
   Curious users           0.189             −0.747   1.124       0.692
   Nonusers                Ref. Cat.                               
   Male                    −1.087            −1.931   −0.244      0.012
   Female                  Ref. Cat.                               
   Age                     −0.113            −0.156   −0.069      \<0.0005
  EQ-5D                                                            
   Intercept               0.866             0.773    0.958       \<0.0005
   Platform use                                                   0.022
   Active users            0.008             −0.031   0.047       0.674
   Curious users           0.044             0.013    0.076       **0.006**
   Nonusers                Ref. Cat.                               
   Male                    0.056             0.027    0.085       \<0.0005
   Female                  Ref. Cat.                               
   Age                     −0.001            −0.002   0.001       0.343
  EQ-VAS                                                           
   Intercept               71.007            61.663   80.350      \<0.0005
   Platform use                                                   0.019
   Active users            2.291             −1.691   6.275       0.259
   Curious users           4.611             1.384    7.838       **0.005**
   Nonusers                Ref. Cat.                               
   Male                    2.977             0.095    5.859       0.043
   Female                  Ref. Cat.                               
   Age                     0.030             −0.118   0.178       0.690
  WHO-5                                                            
   Intercept               58.138            48.911   67.365      \<0.0005
   Platform use                                                   0.065
   Active users            −0.089            −4.008   3.829       0.964
   Curious users           3.609             0.446    6.773       **0.025**
   Nonusers                Ref. Cat.                               
   Male                    5.766             2.932    8.600       \<0.0005
   Female                  Ref. Cat.                               
   Age                     0.142             −0.004   0.289       0.057
  PAID-5                                                           
   Intercept               5.129             3.520    6.737       \<0.0005
   Platform use                                                   0.004
   Active users            −0.511            −1.195   0.173       0.143
   Curious users           −0.929            −1.480   −0.378      **0.001**
   Nonusers                Ref. Cat.                               
   Male                    −0.143            −0.639   0.353       0.571
   Female                  Ref. Cat.                               
   Age                     −0.037            −0.062   −0.011      0.005
  SDSCA-medication                                                 
   Intercept               6.087             5.575    6.600       \<0.0005
   Platform use                                                   0.028
   Active users            0.081             −0.132   0.296       0.458
   Curious users           0.236             0.063    0.408       **0.008**
   Nonusers                Ref. Cat.                               
   Male                    0.096             −0.058   0.250       0.222
   Female                  Ref. Cat.                               
   Age                     0.010             0.002    0.018       0.020

###### 

Demographic and clinical characteristics of users and nonusers.

  --------------------------------------------------------------------------------------------------------------------------------
  Demographic and clinical parameters  \        Nonusers (*n* = 361)   Missing      Users (*n* = 272)   Missing     Univariate \
  *n* (%)/mean ± SD/median (25--75 quartiles)                                                                       *p* value
  --------------------------------------------- ---------------------- ------------ ------------------- ----------- --------------
  Men                                           214 (59.3)             0 (0)        163 (59.9)          0 (0)       0.95

  Age in years                                  62.1 ± 9.5  \          0 (0)        61.8 ± 9.4 \        0 (0)       0.732
                                                63.0 (56.5--68.0)                   62.5 (57.0--68.0)               

  Ethnicity                                                                                                          

   Caucasian                                    292 (99.0)             66 (18.3)    208 (100)           64 (2.5)    0.271

   Other                                        3 (1.0)                             0 (0)                            

  T2DM duration in years                        6.2 ± 4.6 \            9 (2.5)      5.6 ± 4.4 \         1 (0.4)     0.068
                                                6.0 (2.0--9.0)                      5.0 (2.0--8.0)                  

  HbA1c in mmol/mol                             50.6 ± 9.5 \           3 (0.8)      48.2 ± 7.3 \        0 (0)       **\<0.0005**
                                                50.0 (45.0--54.0)                   47.0 (43.0--53.0)               

  BMI                                           29.8 ± 4.9 \           3 (0.8)      30.0 ± 6.0 \        2 (0.7)     0.724
                                                29.0 (26.5--32.5)                   28.7 (26.3--32.4)               

  Systolic blood pressure in mmHG               135.6 ± 15.5           0 (0)        136.5 ± 16.0        4 (1.5)     0.463

  Cholesterol in mmol/L                         4.4 ± 1.0              4 (1.1)      4.4 ± 0.9           2 (0.7)     0.499

  HDL in mmol/L                                 1.3 ± 0.4              4 (1.1)      1.3 ± 0.4           3 (1.1)     0.581

  Cholesterol/HDL ratio                         3.6 ± 1.1              160 (44.3)   3.6 ± 1.3           92 (33.8)   0.899

  LDL in mmol/L                                 2.4 ± 0.9              12 (3.3)     2.3 ± 0.8           6 (2.2)     0.240

  Triglycerides in mmol/L                       1.7 ± 1.0 \            7 (1.9)      1.8 ± 1.2 \         2 (0.7)     0.482
                                                1.5 (1.0--2.1)                      1.5 (1.1--2.1)                  

  Creatinine in *µ*mol/L                        78.6 ± 17.2 \          6 (1.7)      79.9 ± 17.5 \       1 (0.4)     0.359
                                                77.0 (67.0--88.0)                   79.0 (67.0--90.0)               

  Alb./creat. ratio in mg/mmol                                                                                       

   Men                                          2.0 ± 4.4 \            23 (10.7)    1.9 ± 5.8 \         25 (15.3)   0.853
                                                0.7 (0.3--1.5)                      0.5 (0.3--1.5)                  

   Women                                        1.6 ± 3.5 \            31 (21.1)    0.9 ± 1.1 \         18 (16.5)   0.070
                                                0.7 (0.3--1.5)                      0.6 (0.4--1.2)                  

  MDRD in mL/min/1.73 m^2^                      79.1 ± 49.0 \          5 (1.4)      76.0 ± 16.6 \       1 (0.4)     0.329
                                                75.0 (61.0--88.0)                   74.0 (61.0--87.0)               

  Smoking                                                                                                            

   Yes                                          54 (15.1)              3 (0.8)      41 (15.1)           1 (0.4)     0.306

   Before                                       158 (44.1)                          104 (38.4)                       

   No                                           146 (40.8)                          126 (46.5)                       

  Alcohol consumption in units/day                                                                                   

   0                                            166 (58.9)             79 (21.9)    139 (60.7)          43 (15.8)   0.870

   1                                            61 (21.6)                           52 (22.7)                        

   2                                            39 (13.8)                           30 (13.1)                        

   3                                            11 (3.9)                            7 (3.1)                          

   4                                            4 (1.4)                             1 (0.4)                          

   5                                            0 (0)                               0 (0)                            

   6                                            1 (0.4)                             0 (0)                            

  Employment                                                                                                         

   Fulltime/part-time working                   99 (34.3)              72 (19.9)    81 (34.0)           34 (12.5)   0.909

   Retired                                      134 (46.4)                          116 (48.7)                       

   Unemployed/ housekeeper                      38 (13.1)                           29 (12.2)                        

   Incapacitated                                18 (6.2)                            12 (5.0)                        

  Educational level                                                                                                  

   None                                         0 (0)                  73 (20.2)    1 (0.4)             35 (12.9)   **0.017**

   Primary school                               24 (8.3)                            13 (5.5)                         

   Low                                          127 (44.1)                          79 (33.3)                        

   Intermediate                                 86 (29.9)                           81 (29.8)                        

   High                                         51 (17.7)                           63 (23.2)                        
  --------------------------------------------------------------------------------------------------------------------------------

###### 

Medication use of users and nonusers.

  -------------------------------------------------------------------------------------------------------------------------
  Medication prescription\                     Nonusers (*n* = 361)   Missing   Users (*n* = 272)   Missing   Univariate\
  *n* (%)                                                                                                     *p* value
  -------------------------------------------- ---------------------- --------- ------------------- --------- -------------
  Diabetes-related                                                                                             

   Oral treatment only                         251 (71.3)             9 (2.5)   192 (71.9)          5 (1.8)   0.702

   Insulin treatment only                      4 (1.1)                9 (2.5)   1 (0.4)             5 (1.8)   0.931

   Mix of oral and insulin treatment           40 (11.4)              9 (2.5)   23 (8.6)            5 (1.8)   0.248

   No medication                               57 (16.2)              9 (2.5)   51 (19.1)           5 (1.8)   0.417

  Comorbidity or complication related                                                                          

   Calcium channel blockers                    50 (14.2)              9 (2.5)   47 (17.6)           5 (1.8)   0.236

   Beta blockers                               128 (36.4)             9 (2.5)   110 (41.2)          5 (1.8)   0.145

   Diuretics                                   121 (34.4)             9 (2.5)   94 (35.2)           5 (1.8)   0.870

   Ace and RAAS inhibitors                     196 (55.7)             9 (2.5)   141 (52.8)          5 (1.8)   0.480

   Other blood pressure lowering medications   3 (0.9)                9 (2.5)   1 (0.4)             5 (1.8)   0.637

   Lipid lowering medication                   280 (79.5)             9 (2.5)   213 (79.8)          5 (1.8)   0.847
  -------------------------------------------------------------------------------------------------------------------------

###### 

Complications and risk factors of users and nonusers.

  ---------------------------------------------------------------------------------------------------------------------------
  Complications and risk factors\          Nonusers (*n* = 361)   Missing      Users (*n* = 272)   Missing      Univariate\
  *n* (%)                                                                                                       *p* value
  ---------------------------------------- ---------------------- ------------ ------------------- ------------ -------------
  Cardiovascular, total                    225 (96.2)             127 (35.2)   187 (98.4)          82 (30.1)    0.240

  Cardiovascular, specific                                                                                       

   Angina pectoris                         41 (21.7)              172 (47.6)   28 (19.7)           130 (47.8)   0.787

   Myocardial infarct                      29 (15.3)              172 (47.6)   23 (16.0)           128 (47.1)   0.880

   Other/chronic ischemic heart diseases   34 (16.1)              150 (41.6)   24 (13.6)           96 (35.3)    0.569

   Hypertension                            191 (84.1)             134 (37.1)   164 (93.2)          96 (35.3)    **0.008**

   TIA                                     12 (6.4)               174 (48.2)   7 (5.0)             133 (48.9)   0.642

   CVA                                     13 (7.0)               176 (48.8)   10 (7.1)            132 (48.5)   1.000

   Intermittent claudication               7 (3.3)                150 (41.6)   7 (4.0)             96 (35.3)    0.788

   Aortic aneurysms                        4 (1.9)                150 (41.6)   2 (1.1)             96 (35.3)    0.693

   CABG                                    15 (5.1)               68 (18.8)    11 (5.4)            68 (25.0)    1.000

   PTCA                                    28 (9.6)               68 (18.8)    14 (6.8)            67 (24.6)    0.327

   Heart failure                           14 (8.1)               189 (52.4)   10 (7.4)            136 (50.0)   0.834

  Retinopathy                              19 (9.3)               156 (43.2)   18 (10.2)           95 (34.9)    0.863

  Renal impairment                         35 (18.6)              173 (47.9)   26 (18.6)           132 (48.5)   1.000

  Albuminuria                                                                                                    

   Men                                     30 (14.5)              7 (3.3)      20 (12.6)           4 (2.5)      0.647

   Women                                   8 (5.8)                8 (5.4)      1 (1.0)             5 (4.6)      0.082

  Neuropathy                               49 (22.2)              140 (38.8)   39 (22.4)           98 (36.0)    1.000

  Foot complication                                                                                              

   SIMMs 0                                 228 (77.6)             67 (18.6)    161 (76.7)          62 (22.8)    0.783

   SIMMs 1                                 57 (19.4)                           40 (19.0)                         

   SIMMs 2 or 3                            9 (3.1)                             9 (4.3)                           

  Psychiatric disorders                    19 (9.0)               150 (41.6)   9 (5.1)             96 (35.3)    0.124
  ---------------------------------------------------------------------------------------------------------------------------

SIMMS refers to risk factors in the diabetic foot, the number is the stage which ranges from 0--3.

0: no loss of protective sensibility (PS) & Peripheral arterial disease (PAV).

1: loss of PS or PAV, with no signs of increased local pressure.

2: loss of PS in combination with and/or PAV and/or signs of local elevated pressure.

3: ulcer or amputation in history.

###### 

Scores on quality of care (Europep) of users and nonusers.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Items of Europep: patients who scored 4 (good) or 5 (excellent) \                                              Nonusers (*n* = 361)   Missing      Users (*n* = 272)   Missing      Univariate\
  *n* (%)                                                                                                                                                                             *p* value
  -------------------------------------------------------------------------------------------------------------- ---------------------- ------------ ------------------- ------------ -------------
  *What is your assessment of the general practitioner over the last 12 months with respect to the following?*                                                                         

  Making you feel you have time during consultation                                                              337 (97.4)             15 (4.2)     256 (98.1)          11 (4.0)     0.622

  Showing interest in your personal situation                                                                    324 (94.5)             18 (5.0)     246 (94.6)          12 (4.4)     0.864

  Making it easy for you to tell him or her about your problem                                                   323 (93.4)             15 (4.2)     245 (96.5)          18 (6.6)     0.110

  Involving you in decisions about your medical care                                                             311 (92.3)             24 (6.6)     239 (94.1)          18 (6.6)     0.290

  Listening to you                                                                                               322 (92.3)             12 (3.3)     243 (94.6)          15 (5.5)     0.270

  Keeping your records and data confidential                                                                     310 (95.7)             37 (10.2)    236 (95.9)          26 (9.6)     0.846

  Providing quick relief of your symptoms                                                                        272 (87.5)             50 (13.9)    201 (85.9)          38 (14.0)    0.635

  Helping you to feel well so that you can perform your normal daily activities                                  265 (89.8)             66 (18.3)    196 (91.2)          57 (21.0)    0.483

  Thoroughness of the approach to your problems                                                                  308 (91.4)             24 (6.6)     227 (89.7)          19 (7.0)     0.786

  Your physical examination                                                                                      292 (90.1)             37 (10.2)    222 (92.1)          31 (11.4)    0.327

  Offering services for preventing diseases (screening, health checks, and immunizations)                        286 (91.4)             48 (13.3)    225 (92.6)          29 (10.7)    0.655

  Explaining the purpose of examinations, tests, and treatments                                                  307 (93.0)             31 (8.6)     240 (93.8)          16 (5.9)     0.518

  Telling you enough about your symptoms and/or illness                                                          306 (92.2)             29 (8.0)     238 (93.3)          17 (6.3)     0.448

  Helping you deal with emotions related to your health status                                                   198 (86.8)             133 (36.8)   133 (84.7)          115 (42.3)   0.888

  Helping understand why it is important to follow the GP\'s advice                                              295 (89.7)             32 (8.9)     219 (89.4)          27 (9.9)     0.894

  Knowing what has been done or told during previous contacts in the practice                                    270 (84.9)             43 (11.9)    219 (89.4)          27 (9.9)     0.071

  Preparing you for what to expect from specialists, hospital care, and other care providers                     199 (85.4)             128 (35.5)   156 (83.5)          85 (31.3)    0.513

                                                                                                                                                                                      

  *What is your assessment of the general practice over the last 12 months with respect to the following?*                                                                             

  The helpfulness of the practice staff (other than the doctor) to you                                           313 (93.4)             26 (7.2)     235 (92.9)          19 (7.0)     0.878

  Getting an appointment to suit you                                                                             301 (88.5)             21 (5.8)     224 (86.5)          13 (4.8)     0.639

  Getting through to the practice on telephone                                                                   249 (73.0)             20 (5.5)     180 (69.5)          13 (4.8)     0.662

  Being able to talk to the general practitioner on the telephone                                                167 (70.5)             124 (34.3)   106 (63.1)          104 (38.2)   0.150

  Waiting time in the waiting room                                                                               246 (71.3)             16 (4.4)     170 (65.4)          12 (4.4)     0.175

  Providing quick services for urgent health problems                                                            241 (90.3)             94 (26.0)    171 (86.8)          75 (27.6)    0.398
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Scores on quality of life (EQ-5D), well-being (WHO-5), diabetes-related distress (PAID-5), and self-care behavior (SDSCA).

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------
  EQ-5D, WHO-5, PAID-5, and SDSCA  \                                          Nonusers (*n* = 361)   Missing      Users\              Missing      Univariate \
  *n* (%)/mean ± SD/median (25--75 quartiles)                                                                     (*n* = 272)                      *p* value
  --------------------------------------------------------------------------- ---------------------- ------------ ------------------- ------------ --------------
  EQ-5D index-score                                                           0.9 ± 0.2              72 (19.9)    0.9 ± 0.1           36 (13.2)    **0.028**

  EQ-VAS                                                                      74.7 ± 17.4 \          74 (20.5)    78.4 ± 14.9 \       40 (14.7)    **0.014**
                                                                              80.0 (60.0--90.0)                   80.0 (71.0--90.0)                

  WHO-5 index-score                                                           70.4 ± 17.9 \          76 (21.1)    72.7 ± 14.2 \       38 (14.0)    0.096
                                                                              76.0 (60.0--80.0)                   76.0 (68.0--80.0)                

  WHO-5 score indicates suboptimal well-being, screening depression advised   36 (12.6)              76 (21.1)    17 (7.3)            38 (14.0)    **0.018**

  WHO-5 answers advise screening depression                                   43 (15.5)              76 (21.1)    17 (7.3)            38 (14.0)    **0.004**

  PAID-5 total score                                                          2.8 ± 3.1 \            76 (21.1)    2.0 ± 2.5 \         38 (14.0)    **0.005**
                                                                              2.0 (0.0--4.5)                      1.0 (0.0--3.0)                   

  PAID-5 score indicates distress                                             15 (5.3)               76 (21.1)    6 (2.6)             38 (14.0)    0.058

  SDSCA                                                                                                                                             

   General diet in number of days                                             5.4 ± 1.8 \            76 (21.1)    5.6 ± 1.8 \         37 (13.6)    0.269
                                                                              6.0 (5.0--7.0)                      6.0 (5.0--7.0)                   

   Specific diet in number of days                                            5.6 ± 1.1 \            73 (20.2)    5.7 ± 1.0 \         34 (12.5)    0.056
                                                                              5.7 (4.7--6.3)                      6.0 (5.3--6.7)                   

   Exercise in number of days                                                 4.0 ± 2.0 \            72 (19.9)    4.0 ± 1.8 \         34 (12.5)    0.919
                                                                              4.0 (2.5--5.5)                      4.0 (2.5--5.5)                   

   Blood-glucose in number of days                                            2.1 ± 2.2 \            74 (20.5)    2.0 ± 2.2 \         34 (12.5)    0.675
                                                                              1.0 (0.0--4.0)                      1.0 (0.5--3.5)                   

   Foot-care in number of days                                                1.9 ± 2.0 \            72 (19.9)    1.9 ± 2.0 \         34 (12.5)    0.695
                                                                              1.5 (0.0--3.5)                      1.0 (0.0--3.5)                   

   Medication in number of days                                               6.7 ± 1.0 \            73 (20.2)    6.9 ± 0.5 \         34 (12.5)    **0.013**
                                                                              7.0 (7.0--7.0)                      7.0 (7.0--7.0)                   

   Smoking                                                                    54 (25.1)              146 (40.4)   38 (22.8)           105 (38.6)   **0.418**
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Demographic and clinical characteristics of curious users, active users, and nonusers.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------
  Demographic and clinical parameters  \        Nonusers\           Missing      Curious users\      Missing     Active users\       Missing     Univariate \
  *n* (%)/mean ± SD/median (25--75 quartiles)   (*n* = 361)                      (*n* = 184)                     (*n* = 88)                      *p* value
  --------------------------------------------- ------------------- ------------ ------------------- ----------- ------------------- ----------- --------------
  Men                                           214 (59.3)          0 (0)        113 (61.4)          0 (0)       50 (56.8)           0 (0)       0.760

  Age in years                                  62.1 ± 9.5 \        0 (0)        61.8 ± 9.5 \        0 (0)       62.0 ± 9.4 \        0 (0)       0.935
                                                63.0 (56.5--68.0)                62.0 (56.3--68.0)               63.0 (57.0--67.0)               

  Ethnicity                                                                                                                                       

   Caucasian                                    292 (99.0)          66 (18.3)    143 (100)           41 (22.3)   65 (100)            23 (6.1)    0.706

   Other                                        3 (1.0)                          0 (0)                           0 (0)                           0.382

  T2DM duration in years                        6.2 ± 4.6 \         9 (2.5)      5.7 ± 4.4  \        1 (0.5)     5.4 ± 4.4 \         0 (0)       0.165
                                                6.0 (2.0--9.0)                   5.0 (2.0--8.0)                  4.5 (2.0--8.0)                  

  HbA1c in mmol/mol                             50.6 ± 9.5 \        3 (0.8)      48.7 ± 7.4 \        0 (0)       47.0 ± 7.0 \        0 (0)       **0.001**
                                                50.0 (45.0--54.0)                48.0 (43.0--54.0)               46.0 (43.0--50.8)               

  BMI                                           29.8 ± 4.9 \        3 (0.8)      30.0 ± 4.8 \        0 (0)       29.9 ± 8.0 \        2 (2.3)     0.921
                                                29.0 (26.5--32.5)                29.3 (26.9--32.3)               28.0 (26.0--32.6)               

  Systolic blood pressure in mmHG               135.6 ± 15.5        0 (0)        137.2 ± 16.3        2 (1.1)     135.1 ± 15.3        2 (2.3)     0.463

  Cholesterol in mmol/L                         4.4 ± 1.0           4 (1.1)      4.4 ± 0.8           0 (0)       4.4 ± 0.9           2 (2.3)     0.775

  HDL in mmol/L                                 1.3 ± 0.4           4 (1.1)      1.2 ± 0.3           1 (0.5)     1.3 ± 0.4           2 (2.3)     0.071

  Cholesterol/HDL ratio                         3.6 ± 1.1           160 (44.3)   3.7 ± 1.4           57 (31.0)   3.4 ± 1.0           35 (39.8)   0.185

  LDL in mmol/L                                 2.4 ± 0.9           12 (3.3)     2.4 ± 0.8           3 (1.6)     2.3 ± 0.8           3 (3.4)     0.473

  Triglycerides in mmol/L                       1.7 ± 1.0 \         7 (1.9)      1.8 ± 1.3 \         0 (0)       1.7 ± 1.0 \         2 (2.3)     0.531
                                                1.5 (1.0--2.1)                   1.5 (1.1--2.1)                  1.4 (1.0--2.0)                  

  Creatinine in *µ*mol/L                        78.6 ± 17.2 \       6 (1.7)      80.9 ± 17.4 \       1 (0.5)     77.8 ± 17.8 \       0 (0)       0.259
                                                77.0 (67.0--88.0)                79.0 (68.0--92.0)               75.5 (66.0--85.8)               

  Alb./creat. ratio in mg/mmol                                                                                                                    

   Men                                          2.0 ± 4.4 \         23 (10.7)    2.2 ± 6.9 \         18 (15.9)   1.3 ± 1.7 \         7 (14.0)    0.636
                                                0.7 (0.3--1.5)                   0.5 (0.3--1.5)                  0.7 (0.3--1.5)                  

   Women                                        1.6 ± 3.5 \         31 (21.1)    1.1 ± 1.3 \         8 (11.3)    0.6 ± 0.5 \         10 (26.4)   0.155
                                                0.7 (0.3--1.5)                   0.7 (0.4--1.5)                  0.6 (0.3--0.9)                  

  MDRD in mL/min/1.73 m^2^                      79.1 ± 49.0 \       5 (1.4)      75.7 ± 16.2 \       1 (0.5)     76.7 ± 17.4 \       0 (0)       0.610
                                                75.0 (61.0--88.0)                73.0 (61.0--87.0)               75.5 (61.0--89.0)               

  Smoking                                                                                                                                         

   Yes                                          54 (15.1)           3 (0.8)      30 (16.4)           1 (0.5)     11 (12.5)           0 (0)       0.382

   Before                                       158 (44.1)                       73 (39.7)                       31 (35.2)                        

   No                                           146 (40.8)                       80 (43.7)                       46 (52.3)                        

  Alcohol consumption in units/day                                                                                                                

   0                                            166 (58.9)          79 (21.9)    98 (60.9)           23 (12.5)   41 (60.3)           20 (22.7)   0.646

   1                                            61 (21.6)                        8 (23.6)                        14 (20.6)                        

   2                                            39 (13.8)                        17 (10.6)                       13 (19.1)                        

   3                                            11 (3.9)                         7 (4.3)                         0 (0)                            

   4                                            4 (1.4)                          1 (0.5)                         0 (0)                            

   5                                            0 (0)                            0 (0)                           0 (0)                            

   6                                            1 (0.4)                          0 (0)                           0 (0)                           

  Employment                                                                                                                                      

   Fulltime/part-time working                   99 (34.3)           72 (19.9)    61 (39.6)           30 (16.3)   20 (23.8)           4 (4.5)     0.063

   Retired                                      134 (46.4)                       70 (45.5)                       46 (54.8)                        

   Unemployed/housekeeper                       38 (13.1)                        20 (13.0)                       9 (10.7)                         

   Incapacitated                                18 (6.2)                         3 (1.9)                         9 (10.7)                         

  Educational level                                                                                                                               

   None                                         0 (0)               73 (20.2)    1 (0.7)             31 (16.8)   0 (0)               4 (4.5)     0.125

   Primary school                               24 (8.3)                         9 (5.9)                         4 (4.8)                          

   Low                                          127 (44.1)                       52 (34.0)                       27 (32.1)                        

   Intermediate                                 86 (29.9)                        51 (33.3)                       30 (35.7)                        

   High                                         51 (17.7)                        40 (26.1)                       23 (27.4)                        
  -------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Medication prescription of curious users, active users, and nonusers.

  ---------------------------------------------------------------------------------------------------------------------------------------
  Medication prescription\                     Nonusers\     Missing   Curious users\   Missing   Active users\   Missing   Univariate\
  *n* (%)                                      (*n* = 361)             (*n* = 184)                (*n* = 88)                *p* value
  -------------------------------------------- ------------- --------- ---------------- --------- --------------- --------- -------------
  Diabetes-related                                                                                                           

   Oral treatment only                         251 (71.3)    9 (2.5)   128 (71.5)       5 (2.7)   64 (72.7)       0 (0)     1.000

   Insulin treatment only                      4 (1.1)       9 (2.5)   1 (0.5)          5 (2.7)   0 (0)           0 (0)     0.899

   Mix of oral and insulin treatment           40 (11.4)     9 (2.5)   18 (10.1)        5 (2.7)   5 (5.7)         0 (0)     0.242

   No medication                               57 (16.2)     9 (2.5)   32 (17.9)        5 (2.7)   19 (21.6)       0 (0)     0.521

  Comorbidity or complication related                                                                                        

   Calcium channel blockers                    50 (14.2)     9 (2.5)   31 (17.3)        5 (2.7)   16 (18.2)       0 (0)     0.415

   Beta blockers                               128 (36.4)    9 (2.5)   74 (41.3)        5 (2.7)   36 (40.9)       0 (0)     0.324

   Diuretics                                   121 (34.4)    9 (2.5)   63 (35.2)        5 (2.7)   31 (35.2)       0 (0)     0.979

   Ace and RAAS inhibitors                     196 (55.7)    9 (2.5)   94 (52.5)        5 (2.7)   47 (53.4)       0 (0)     0.738

   Other blood pressure lowering medications   3 (0.9)       9 (2.5)   0 (0)            5 (2.7)   1 (1.1)         0 (0)     0.357

   Lipid lowering medication                   280 (79.5)    9 (2.5)   141 (78.8)       5 (2.7)   72 (81.8)       0 (0)     0.868
  ---------------------------------------------------------------------------------------------------------------------------------------

###### 

Complications and risk factors of curious users, active users, and nonusers.

  ------------------------------------------------------------------------------------------------------------------------------------------
  Complications and risk factors\          Nonusers\     Missing      Curious users\   Missing     Active users\   Missing     Univariate\
  *n* (%)                                  (*n* = 361)                (*n* = 184)                  (*n* = 88)                  *p* value
  ---------------------------------------- ------------- ------------ ---------------- ----------- --------------- ----------- -------------
  Cardiovascular, total                    225 (96.2)    127 (35.2)   128 (98.5)       54 (29.3)   59 (98.3)       28 (31.8)   0.506

  Cardiovascular, specific                                                                                                      

   Angina pectoris                         41 (21.7)     172 (47.6)   21 (21.4)        86 (46.7)   7 (15.9)        44 (50.0)   0.698

   Myocardial infarct                      29 (15.3)     172 (47.6)   15 (15.3)        86 (46.7)   8 (17.4)        42 (47.7)   0.932

   Other/chronic ischemic heart diseases   34 (16.1)     150 (41.6)   18 (14.9)        63 (34.2)   6 (10.9)        33 (37.5)   0.750

   Hypertension                            191 (84.1)    134 (37.1)   113 (93.4)       63 (34.2)   51 (92.7)       33 (37.5)   **0.025**

   TIA                                     12 (6.4)      174 (48.2)   4 (4.2)          88 (47.8)   3 (7.0)         45 (51.1)   0.747

   CVA                                     13 (7.0)      176 (48.8)   6 (6.1)          86 (46.7)   4 (9.5)         46 (52.3)   0.745

   Intermittent claudication               7 (3.3)       150 (41.6)   4 (3.3)          63 (34.2)   3 (5.5)         33 (37.5)   0.689

    Aortic aneurysms                       4 (1.9)       150 (41.6)   1 (0.8)          63 (34.2)   1 (1.8)         33 (37.5)   0.731

   CABG                                    15 (5.1)      68 (18.8)    7 (5.0)          43 (23.4)   4 (6.3)         25 (28.4)   0.916

   PTCA                                    28 (9.6)      68 (18.8)    9 (6.4)          43 (23.4)   5 (7.8)         24 (27.3)   0.588

   Heart failure                           14 (8.1)      189 (52.4)   9 (9.4)          88 (47.8)   1 (2.5)         48 (54.5)   0.409

  Retinopathy                              19 (9.3)      156 (43.2)   14 (11.7)        64 (34.8)   4 (7.0)         31 (35.2)   0.640

  Renal impairment                         35 (18.6)     173 (47.9)   15 (15.5)        87 (47.3)   11 (25.6)       45 (51.1)   0.350

  Albuminuria                                                                                                                   

   Men                                     30 (14.5)     7 (3.3)      14 (12.6)        2 (1.8)     6 (12.5)        2 (4.0)     0.908

   Women                                   8 (5.8)       8 (5.4)      1 (1.4)          1 (1.4)     0 (0)           4 (10.5)    0.226

  Neuropathy                               49 (22.2)     140 (38.8)   30 (24.6)        62 (33.7)   9 (17.3)        36 (40.9)   0.594

  Foot complication                                                                                                             

   SIMMs 0                                 228 (77.6)    67 (18.6)    105 (73.4)       41 (22.3)   56 (83.6)       21 (23.9)   0.524

   SIMMs 1                                 57 (19.4)                  31 (21.7)                    9 (13.4)                     

   SIMMs 2 or 3                            9 (3.1)                    7 (4.9)                      2 (3.0)                      

  Psychiatric disorders                    19 (9.0)      150 (41.6)   7 (5.8)          63 (34.2)   2 (3.6)         33 (37.5)   0.317
  ------------------------------------------------------------------------------------------------------------------------------------------

###### 

Scores on quality of care (Europep) of curious users, active users, and nonusers.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Items of Europep: patients who scored 4 (good) to 5 (excellent)\                                               Nonusers (*n* = 361)   Missing      Curious users (*n* = 184)   Missing     Active users (*n* = 88)   Missing     Univariate\
  *n* (%)                                                                                                                                                                                                                          *p* value
  -------------------------------------------------------------------------------------------------------------- ---------------------- ------------ --------------------------- ----------- ------------------------- ----------- -------------
  *What is your assessment of the general practitioner over the last 12 months with respect to the following?*                                                                                                                      

  Making you feel that you have time during consultation                                                         737 (95.1)             105 (11.9)   174 (99.4)                  9 (4.9)     82 (95.3)                 2 (2.3)     0.159

  Showing interest in your personal situation                                                                    707 (91.6)             108 (12.3)   165 (94.8)                  10 (5.4)    81 (94.2)                 2 (2.3)     0.970

  Making it easy for you to tell him or her about your problem                                                   694 (92.2)             127 (14.4)   165 (98.2)                  16 (8.7)    80 (93.0)                 2 (2.3)     **0.047**

  Involving you in decisions about your medical care                                                             680 (90.7)             130 (14.8)   159 (93.5)                  14 (7.6)    80 (95.2)                 4 (4.5)     0.489

  Listening to you                                                                                               709 (92.0)             109 (12.4)   163 (94.8)                  12 (6.5)    80 (94.1)                 3 (3.4)     0.579

  Keeping your records and data confidential                                                                     661 (93.8)             175 (19.9)   161 (97.0)                  18 (9.8)    75 (93.8)                 8 (9.1)     0.764

  Providing quick relief of your symptoms                                                                        588 (83.9)             179 (20.3)   137 (86.2)                  25 (13.6)   64 (85.3)                 13 (14.8)   0.863

  Helping you to feel well so that you can perform your normal daily activities                                  599 (89.7)             212 (24.1)   135 (91.8)                  37 (20.1)   61 (89.7)                 20 (22.7)   0.780

  Thoroughness of the approach to your problems                                                                  675 (90.7)             136 (15.5)   153 (90.5)                  15 (8.2)    74 (88.1)                 4 (4.5)     0.769

  Your physical examination                                                                                      639 (90.8)             176 (20.0)   153 (92.7)                  19 (10.3)   69 (90.8)                 12 (13.6)   0.577

  Offering services for preventing diseases (screening, health checks, and immunizations)                        653 (92.5)             174 (19.8)   151 (91.5)                  19 (10.3)   74 (94.9)                 10 (11.4)   0.539

  Explaining the purpose of examinations, tests, and treatments                                                  677 (92.4)             147 (16.7)   163 (94.8)                  12 (6.5)    77 (91.7)                 4 (4.5)     0.402

  Telling you enough about your symptoms and/or illness                                                          662 (90.2)             146 (16.6)   158 (92.4)                  13 (7.1)    80 (95.2)                 4 (4.5)     0.579

  Helping you deal with emotions related to your health status                                                   424 (84.8)             380 (43.2)   89 (86.4)                   81 (44.0)   44 (81.5)                 34 (38.6)   0.659

  Helping understand why it is important to follow the GP\'s advice                                              631 (89.1)             172 (19.5)   146 (89.6)                  21 (11.4)   73 (89.0)                 6 (6.8)     0.965

  Knowing what has been done or told during previous contacts in the practice                                    601 (86.8)             188 (21.4)   148 (90.2)                  20 (10.9)   71 (87.7)                 7 (8.0)     0.158

  Preparing you for what to expect from specialists, hospital care, and other care providers                     424 (82.8)             368 (41.8)   107 (8.3)                   54 (29.3)   49 (86.0)                 31 (35.2)   0.577

                                                                                                                                                                                                                                   

  *What is your assessment of the general practice over the last 12 months with respect to the following?*                                                                                                                          

  The helpfulness of the practice staff (other than the doctor) to you                                           313 (93.4)             26 (7.2)     158 (92.9)                  14 (7.6)    77 (92.8)                 5 (5.7)     0.953

  Getting an appointment to suit you                                                                             301 (88.5)             21 (5.8)     152 (86.9)                  9 (4.9)     72 (85.7)                 4 (4.5)     0.867

  Getting through to the practice on telephone                                                                   249 (73.0)             20 (5.5)     120 (68.6)                  9 (4.9)     60 (71.4)                 4 (4.5)     0.777

  Being able to talk to the general practitioner on the telephone                                                167 (70.5)             124 (34.3)   71 (62.8)                   71 (38.6)   35 (63.6)                 33 (37.5)   0.306

  Waiting time in the waiting room                                                                               246 (71.3)             16 (4.4)     119 (68.4)                  10 (5.4)    51 (59.3)                 2 (2.3)     0.148

  Providing quick services for urgent health problems                                                            241 (90.3)             94 (26.0)    118 (86.8)                  48 (26.1)   53 (86.9)                 27 (30.7)   0.658
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Scores on quality of life (EQ-5D), well-being (WHO-5), diabetes-related distress (PAID-5), and self-care behavior (SDSCA) of curious users, active users, and nonusers.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  EQ-5D, WHO-5, PAID-5, and SDSCA \                                           Nonusers\           Missing      Curious users\      Missing     Active users\       Missing     Univariate \
  *n* (%)/mean ± SD/median (25--75 quartiles)                                 (*n* = 361)                      (*n* = 184)                     (*n* = 88)                      *p* value
  --------------------------------------------------------------------------- ------------------- ------------ ------------------- ----------- ------------------- ----------- --------------
  EQ-5D index-score                                                           0.9 ± 0.2           72 (19.9)    0.9 ± 0.1           32 (17.4)   0.9 ± 0.2           4 (4.5)     **0.030**

  EQ-VAS                                                                      74.7 ± 17.4 \       74 (20.5)    79.3 ± 13.8 \       35 (19.0)   76.9 ± 16.5 \       5 (5.7)     **0.032**
                                                                              80.0 (60.0--90.0)                80.0 (73.0--90.0)               80.0 (0.0--90.0)                

  WHO-5 index-score                                                           70.4 ± 17.9 \       76 (21.1)    74.1 ± 12.7 \       33 (17.9)   70.2 ± 16.5 \       1 (1.1)     0.080
                                                                              76.0 (60.0--80.0)                76.0 (68.0--80.0)               76.0 (60.0--80.0)               

  WHO-5 score indicates suboptimal well-being, screening depression advised   36 (12.6)           76 (21.1)    8 (5.3)             33 (17.9)   9 (10.8)            1 (1.1)     **0.018**

  WHO-5 answers advise screening depression                                   43 (15.5)           76 (21.1)    6 (4.0)             33 (17.9)   11 (13.3)           1 (1.1)     **0.002**

  PAID-5 total score                                                          2.8 ± 3.1 \         76 (21.1)    1.8 ± 2.4 \         32 (17.4)   2.2 ± 2.5 \         1 (1.1)     **0.016**
                                                                              2.0 (0.0--4.5)                   1.0 (0.0--3.0)                  1.0 (0.0--4.0)                  

  PAID-5 score indicates distress                                             15 (5.3)            76 (21.1)    4 (2.6)             32 (17.4)   2 (2.4)             1 (1.1)     0.183

  SDSCA                                                                                                                                                                         

   General diet in number of days                                             5.4 ± 1.8 \         76 (21.1)    5.5 ± 1.9 \         32 (17.4)   5.8 ± 1.7 \         5 (5.7)     0.258
                                                                              6.0 (5.0--7.0)                   6.0 (5.0--7.0)                  6.0 (5.5--7.0)                  

   Specific diet in number of days                                            5.6 ± 1.1 \         73 (20.2)    5.7 ± 1.0 \         30 (16.3)   5.7 ± 1.0 \         4 (4.5)     0.160
                                                                              5.7 (4.7--6.3)                   6.0 (5.0--6.7)                  6.0 (5.3--6.6)                  

   Exercise in number of days                                                 4.0 ± 2.0 \         72 (19.9)    4.1 ± 1.8 \         30 (16.3)   3.8 ± 1.8 \         4 (4.5)     0.612
                                                                              4.0 (2.5--5.5)                   4.0 (2.9--5.6)                  3.8 (2.5--5.0)                  

   Blood-glucose in number of days                                            2.1 ± 2.2 \         74 (20.5)    2.1 ± 2.4 \         30 (16.3)   1.8 ± 1.8 \         4 (4.5)     0.241
                                                                              1.0 (0.0--4.0)                   1.0 (0.0--4.0)                  1.0 (0.5--2.3)                  

   Foot-care in number of days                                                1.9 ± 2.0 \         72 (19.9)    1.9 ± 2.0 \         30 (16.3)   1.8 ± 2.0 \         4 (4.5)     0.924
                                                                              1.5 (0.0--3.5)                   1.0 (0.0--3.5)                  1.0 (0.0--3.5)                  

   Medication in number of days                                               6.7 ± 1.0 \         73 (20.2)    7.0 ± 0.2 \         30 (16.3)   6.8 ± 0.8 \         4 (4.5)     **0.020**
                                                                              7.0 (7.0--7.0)                   7.0 (7.0--7.0)                  7.0 (7.0--7.0)                  

   Smoking                                                                    54 (25.1)           146 (40.4)   24 (21.8)           74 (40.2)   14 (24.6)           31 (35.2)   0.704
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

[^1]: Academic Editor: Nitin Gupta
